Differential nucleocytoplasmic shuttling of beta-arrestins. Characterization of a leucine-rich nuclear export signal in beta-arrestin2.
about
Arrestins: ubiquitous regulators of cellular signaling pathwaysDegradation of endocytosed epidermal growth factor and virally ubiquitinated major histocompatibility complex class I is independent of mammalian ESCRTIIMdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2β-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expressionA scanning peptide array approach uncovers association sites within the JNK/beta arrestin signalling complexBeta-arrestin-dependent mu-opioid receptor-activated extracellular signal-regulated kinases (ERKs) Translocate to Nucleus in Contrast to G protein-dependent ERK activationThe structural basis of arrestin-mediated regulation of G-protein-coupled receptorsThe emerging roles of β-arrestins in fibrotic diseasesMultifaceted role of β-arrestins in inflammation and diseaseNuclear GPCRs in cardiomyocytes: an insider's view of β-adrenergic receptor signalingCortical recruitment and nuclear-cytoplasmic shuttling of Scd5p, a protein phosphatase-1-targeting protein involved in actin organization and endocytosisSubcellular localization of beta-arrestins is determined by their intact N domain and the nuclear export signal at the C terminusR7BP augments the function of RGS7*Gbeta5 complexes by a plasma membrane-targeting mechanismBeta-arrestins: multifunctional cellular mediatorsTargeting of beta-arrestin2 to the centrosome and primary cilium: role in cell proliferation controlβArrestin1 regulates the guanine nucleotide exchange factor RasGRF2 expression and the small GTPase Rac-mediated formation of membrane protrusion and cell motility.Non-visual arrestins are constitutively associated with the centrosome and regulate centrosome function.Beyond desensitization: physiological relevance of arrestin-dependent signaling.Beta-arrestin2 functions as a phosphorylation-regulated suppressor of UV-induced NF-kappaB activation.Distinct cellular and subcellular distributions of G protein-coupled receptor kinase and arrestin isoforms in the striatum.Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and beta-arrestins.Location-dependent signaling of the group 1 metabotropic glutamate receptor mGlu5.Intact MDM2 E3 ligase activity is required for the cytosolic localization and function of β-arrestin2Carboxyl-terminal and intracellular loop sites for CRF1 receptor phosphorylation and beta-arrestin-2 recruitment: a mechanism regulating stress and anxiety responsesIdentification of arrestin-3-specific residues necessary for JNK3 kinase activationA single mutation in arrestin-2 prevents ERK1/2 activation by reducing c-Raf1 binding.Nuclear functions for plasma membrane-associated proteins?Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signalingMultifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling.β-arrestin1 over-expression is associated with an unfavorable prognosis in lung adenocarcinomas and correlated with vascular endothelial growth factor.Identification of a nuclear localization sequence in β-arrestin-1 and its functional implicationsPlasma membrane and nuclear localization of G protein coupled receptor kinase 6A.Silent scaffolds: inhibition OF c-Jun N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutantbeta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53.Sunday Driver links axonal transport to damage signaling.Cone arrestin binding to JNK3 and Mdm2: conformational preference and localization of interaction sitesVisual and both non-visual arrestins in their "inactive" conformation bind JNK3 and Mdm2 and relocalize them from the nucleus to the cytoplasm.Interference with ERK(Thr188) phosphorylation impairs pathological but not physiological cardiac hypertrophy.The β-Arrestins: Multifunctional Regulators of G Protein-coupled ReceptorsAltered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by l-DOPA treatment.
P2860
Q21184142-A2588C54-01E4-4FA5-83D2-D66F654CD762Q24299540-7D667221-D831-484C-864D-D362506E8AD5Q24305064-C6973A32-11FB-46F6-AEB6-390096F09F7BQ24306884-4F375D64-82B8-4B8D-BF48-2F91E812F845Q24318846-F1D9B684-E1F5-478A-A28D-9F37A87C3F0AQ24644106-708129BD-A124-411E-B246-7B439E1459D6Q24657537-4ADD1141-99FB-487D-B494-CE046E4E6E09Q26783047-9D5DE939-BE0D-4640-8A34-16035CE16F5BQ26785883-E72756BA-12D8-4960-B28B-7AFE7B1479B7Q27026973-5C789AAB-54A2-4EEB-9329-3AF9340E3B50Q27938004-109C88BC-D5CB-4A40-9E63-3AB674141624Q28204316-1A25D9A3-AF21-4ECC-ADFC-A70279422FDAQ28254091-F0AEDE31-C70A-4EEC-A23F-DD36BA525CB2Q28268438-910D007C-81AB-42B5-B22B-17E09CBA8729Q28571736-90ACD758-0A33-4733-A651-F1DE1D5FE555Q33676791-5098227D-4AA6-459D-9502-995894173923Q33707151-5FCEF5A3-CC11-4EB2-9A5D-50C28E822BE9Q33890802-FADCE78F-BB08-4182-AE89-BF9263C8162CQ34324913-F75B5C32-83D2-4EAA-8E47-8C89FB6AB060Q34472138-21ACF05B-C3D6-48B9-80B6-9268C5591051Q34564790-CCAC12B0-09B3-4CEC-B5E7-1A465C426609Q34573953-AAE0E6B9-E077-45C7-971A-2ECEBF5B0439Q34888305-B94511D1-DC91-44E8-A105-E64C5C94268EQ35009538-875D8B1D-F3AE-4973-81FE-41B7C6C12678Q35150024-39675186-99FD-46C1-A587-6098621708F8Q35156778-DEDA390B-F69D-481A-95F0-1A88DD40EDB8Q35168502-00E678C0-85A8-4824-A8AD-6AFED75F5FA0Q35201347-ABC5503E-80BD-41BA-BE65-5CE5C5753C27Q35213474-CF6701CB-7658-4341-8CC9-1829E07440A5Q35741012-49428F8E-21A0-4156-9942-93830B053691Q35841971-9660CA40-03A8-4F92-AF9F-4DC7D901AA65Q35942465-CE73EC14-7C2B-44AB-AAFE-33CD0CD1E492Q36003914-13C2D74E-6123-46B3-854C-FD9B270E9B98Q36156773-AE3D8884-8C2F-49A3-B8DF-DE781FCE2A64Q36321488-851BC869-8168-41BB-846B-12339DA3EB6DQ36726873-31B8DCD2-987A-45F1-829C-E3887695B591Q36726881-B01A5788-F6A6-42FB-979F-A0CCE9AB87F2Q36820215-8DB3776A-C748-4BC8-A694-35AC9EF48285Q36884777-9714D419-FB58-4996-9914-C50652F44186Q37067437-2E0D9428-E31D-48C5-AFF7-BA10CD5288B1
P2860
Differential nucleocytoplasmic shuttling of beta-arrestins. Characterization of a leucine-rich nuclear export signal in beta-arrestin2.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Differential nucleocytoplasmic ...... port signal in beta-arrestin2.
@en
Differential nucleocytoplasmic ...... port signal in beta-arrestin2.
@nl
type
label
Differential nucleocytoplasmic ...... port signal in beta-arrestin2.
@en
Differential nucleocytoplasmic ...... port signal in beta-arrestin2.
@nl
prefLabel
Differential nucleocytoplasmic ...... port signal in beta-arrestin2.
@en
Differential nucleocytoplasmic ...... port signal in beta-arrestin2.
@nl
P2093
P2860
P50
P356
P1476
Differential nucleocytoplasmic ...... port signal in beta-arrestin2.
@en
P2093
Axel Périanin
Erwann Le Rouzic
Hervé Enslen
Mark G H Scott
Vincenzo Pierotti
P2860
P304
37693-37701
P356
10.1074/JBC.M207552200
P407
P577
2002-08-06T00:00:00Z